Antibodies to the estrogen receptor‐α modulate rapid prolactin release from rat pituitary tumor cells through plasma membrane estrogen receptors
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Antibodies (Abs) raised against the estrogen receptor‐α (ERα) were used to investigate the role of ERα proteins located at the plasma membrane in mediating the rapid, estrogen‐stimulated secretion of prolactin (PRL) from rat pituitary GH 3 /B6/F10 cells. Exposure of the cells to 1 nM 17 β‐estradiol (E 2 ) significantly increased PRL release after 3 or 6 min. When ERα Abs that bind specifically to ERα but are too large to diffuse into cells were tested for activity at the cell membrane, Ab R4, targeted to an ERα hinge region sequence, increased PRL release in a time‐ and concentration‐dependent fashion. Ab H151, directed against a different hinge region epitope, decreased PRL release and blocked the stimulatory action of E 2 . Abs raised against the DNA binding domain (H226) or the carboxyl terminus (C542) were not biologically active. When each Ab was examined for recognition of ERα on the cell surface by immunocytochemistry, all except H151 generated immunostaining in aldehyde‐fixed cells. In live cells, however, Ab H151 but not Ab R4 blocked the membrane binding of fluorescently tagged E 2 ‐BSA. Overall, the data indicate that plasma membrane ERα proteins mediate estrogen‐stimulated PRL release from GH 3 /B6/F10 cells. These results may also convey information about conformationally sensitive areas of the membrane form of ERα involved in rapid, nongenomic responses to estrogens.—Norfleet, A. M., Clarke, C. H., Gametchu, B., Watson, C. S. Antibodies to the estrogen receptor‐α modulate rapid prolactin release from rat pituitary tumor cells through plasma membrane estrogen receptors. FASEB J. 14, 157–165 (2000)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aronica, S. M., Kraus, W. L., & Katzenellenbogen, B. S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8517 · Cited by 670 · cited 1×
“The short latency of these responses is considered to preclude the involvement of de novo mRNA or protein synthesis, a consideration that has been corroborated in some experiments using pharmacological inhibitors of transcription and translation ( 5 ).”
ResultAnesthetic Effect of Steroid Hormones.
Selye, H. (1941) · Experimental Biology and Medicine · doi:10.3181/00379727-46-11907 · Cited by 375
Cited by
Multiple Actions of Steroid Hormones—A Focus on Rapid, Nongenomic Effects
Falkenstein, E., Tillmann, H.-C., Christ, M., Feuring, M., & Wehling, M. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01468-6 · Cited by 991
Rapid actions of plasma membrane estrogen receptors
Kelly, M. J., & Levin, E. R. (2001) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(01)00377-0 · Cited by 643
Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model
Norman, A. W., Mizwicki, M. T., & Norman, D. P. G. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1283 · Cited by 569
Nongenomic steroid action: controversies, questions, and answers
LÖSEL, R. M., FALKENSTEIN, E., FEURING, M., SCHULTZ, A., TILLMANN, H.-C., ROSSOL-HASEROTH, K., & WEHLING, M. (2003) · Physiological Reviews · doi:10.1152/physrev.00003.2003 · Cited by 561
“An antibody (Ab R4) against the hinge region of ER increased prolactin release in a time- and concentration-dependent manner, whereas Ab H151 targeted against a different hinge region epitope decreased prolactin release and blocked the effects of 17 -estradiol (337).”
BackgroundEstrogen Prevents the Lipopolysaccharide-Induced Inflammatory Response in Microglia
Vegeto, E., Bonincontro, C., Pollio, G., Sala, A., Viappiani, S., Nardi, F., Brusadelli, A., Viviani, B., Ciana, P., & Maggi, A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-06-01809.2001 · Cited by 471
Metadata
- Authors
- NORFLEET, A. M., CLARKE, C. H., GAMETCHU, B., & WATSON, C. S.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2000-01
- Volume
- 14
- Issue
- 1
- Pages
- 157-165
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W1543854743
- Cited by
- 129
- References
- 2
- FWCI
- 8.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.